Regulatory News - Americas
March 27, 2018 / 11:44 AM / a year ago

BRIEF-Imprimis Pharmaceuticals Issued Composition Patent For Non-Opioid Conscious Sedation Formulation

1 Min Read

March 27 (Reuters) - Imprimis Pharmaceuticals Inc:

* IMPRIMIS PHARMACEUTICALS ISSUED COMPOSITION PATENT FOR NON-OPIOID CONSCIOUS SEDATION FORMULATION

* IMPRIMIS PHARMACEUTICALS INC - ‍SECURED A PATENT COVERING COMPANY’S MKO MELT COMPOUNDED FORMULATION​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below